Protalix BioTherapeutics
PLX
#8648
Rank
S$0.10 B
Marketcap
$1.43
Share price
-4.35%
Change (1 day)
-38.70%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2023 (TTM): $0.13

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is $0.13. In 2022 the company made an earnings per share (EPS) of -$0.39 an increase over its 2021 EPS that were of -$0.81.

EPS history for Protalix BioTherapeutics from 1999 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$0.13-133.6%
2022-$0.39-51.61%
2021-$0.81342.86%
2020-$0.18-88.71%
2019-$1.62-34.74%
2018-$2.47-70.92%
2017-$8.512153.35%
2016-$0.38-146.77%
2015$0.81-287.88%
2014-$0.4310%
2013-$0.39130.77%
2012-$0.17-56.67%
2011-$0.39-46.43%
2010-$0.7336.59%
2009-$0.5332.26%
2008-$0.40-93.4%
2007-$6.121298.53%
2006-$0.44-96.59%
2005-$12.8419.32%
2004-$10.761552.65%
2003-$0.65-0%
2002-$0.65-50%
2001-$1.30233.33%
2000-$0.39-84.21%
1999-$2.47

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.83-740.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.55 1,860.00%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.42 1,760.00%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.61-2,100.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel